The two methyls that turn a 2-minute hormone into a 1-week drug

Glucagon-like peptide-1 (GLP-1) is the gut hormone your body releases after a meal. It tells your pancreas to release insulin and signals your brain that you are full. As a drug, it is also useless. An enzyme called DPP-4 cleaves the natural hormone within about two minutes, which is exactly why your body is comfortable producing it: it disappears as fast as it appears.

Turning a two-minute molecule into a once-a-week drug required engineering. Semaglutide makes three changes to the natural sequence. The most consequential of them is a single residue swap at position 8: L-alanine becomes α-aminoisobutyric acid (Aib). Many sequence charts encode it as X.

Why a methyl group is a wall

Alanine has a methyl side chain, a chiral α-carbon, and a single hydrogen at the α-position. Aib has two methyl groups instead. Sterically, that doubled methyl is a wall. DPP-4 is exquisitely shaped to cleave just behind a small residue at position 2 of GLP-1 (numbered as position 8 in the parent prepro-glucagon sequence). Aib will not fit. Drugs that use it survive in plasma for hours instead of seconds.

There is a second consequence: Aib has no α-hydrogen. With both substituents identical, the residue is achiral, and its torsional preferences favor helix. Inserting Aib into the N-terminus rigidifies the helical entry of the peptide into the GLP-1 receptor pocket, modestly improving binding fidelity in the bound state.

A residue your body never makes is what lets the receptor see the drug seven days after the injection.

A pattern, not a one-off

Tirzepatide, the dual GLP-1/GIP receptor agonist, uses the same trick — twice. Aib at position 2 blocks DPP-4 the same way semaglutide does. A second Aib mid-chain locks central helix geometry, which matters because tirzepatide must dock into two different receptor pockets without losing its shape. Ipamorelin, a five-residue ghrelin agonist, opens with Aib for the same reason.

Read against this lineage, the answer to "why does semaglutide cost what it costs to develop?" comes into focus. The molecule is not a complicated polymer — it is a 31-residue chain. The cleverness is in the placement of three small modifications, of which Aib at position 8 is the load-bearing one.

Visualize the swap

If you pull up any published semaglutide sequence diagram, find position 8 (sometimes labeled position 2 in GLP-1 numbering): that is where Aib replaces alanine. The two methyl groups look tiny on paper, but sterically they are what blocks DPP-4 long enough for albumin binding and weekly dosing to matter.